BR0009573A - Composições e métodos para o tratamento e diagnose do câncer de mama - Google Patents

Composições e métodos para o tratamento e diagnose do câncer de mama

Info

Publication number
BR0009573A
BR0009573A BR0009573-7A BR0009573A BR0009573A BR 0009573 A BR0009573 A BR 0009573A BR 0009573 A BR0009573 A BR 0009573A BR 0009573 A BR0009573 A BR 0009573A
Authority
BR
Brazil
Prior art keywords
breast cancer
compositions
treatment
methods
diagnosis
Prior art date
Application number
BR0009573-7A
Other languages
English (en)
Inventor
Tony N Frudakis
John M Smith
Steven G Reed
Lynda Misher
Marc W Retter
Davin C Dillon
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/289,198 external-priority patent/US6586570B1/en
Priority claimed from US09/429,755 external-priority patent/US6656480B2/en
Priority claimed from US09/534,825 external-priority patent/US6861506B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of BR0009573A publication Critical patent/BR0009573A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"COMPOSIçõES E MéTODOS PARA O TRATAMENTO E DIAGNOSE DO CâNCER DE MAMA". Apresentam-se composições e métodos para detecção e terapia do câncer de mama. Os compostos providenciados incluem seq³ências de nucleotídeo que são de preferência expressos em tecido de tumor de mama, bem como polipeptídeos codificados por tais seq³ências de nucleotídeo. São também providenciadas vacinas e composições farmacêuticas compreendendo tais compostos, que podem ser usadas, por exemplo, na prevenção e tratamento do câncer de mama. Os polipeptídeos também podem se usados para produção de anticorpos, que são úteis para diagnóstico e monitoração do progresso do câncer de mama em um paciente.
BR0009573-7A 1999-04-09 2000-04-07 Composições e métodos para o tratamento e diagnose do câncer de mama BR0009573A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/289,198 US6586570B1 (en) 1996-01-11 1999-04-09 Compositions and methods for the treatment and diagnosis of breast cancer
US09/429,755 US6656480B2 (en) 1996-01-11 1999-10-28 Compositions and methods for the treatment and diagnosis of breast cancer
US09/534,825 US6861506B1 (en) 1996-01-11 2000-03-23 Compositions and methods for the treatment and diagnosis of breast cancer
PCT/US2000/009312 WO2000061753A2 (en) 1999-04-09 2000-04-07 Compositions and methods for the treatment and diagnosis of breast cancer

Publications (1)

Publication Number Publication Date
BR0009573A true BR0009573A (pt) 2002-04-16

Family

ID=27403868

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009573-7A BR0009573A (pt) 1999-04-09 2000-04-07 Composições e métodos para o tratamento e diagnose do câncer de mama

Country Status (15)

Country Link
EP (1) EP1169444A2 (pt)
JP (1) JP2002541803A (pt)
KR (1) KR20020026418A (pt)
CN (1) CN1352683A (pt)
AU (1) AU774824B2 (pt)
BR (1) BR0009573A (pt)
CA (1) CA2365909A1 (pt)
CZ (1) CZ20013575A3 (pt)
HU (1) HUP0200825A2 (pt)
IL (1) IL145719A0 (pt)
MX (1) MXPA01010186A (pt)
NO (1) NO20014805L (pt)
NZ (1) NZ514646A (pt)
PL (1) PL350863A1 (pt)
WO (1) WO2000061753A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828431B1 (en) 1999-04-09 2004-12-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6656480B2 (en) 1996-01-11 2003-12-02 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6586570B1 (en) 1996-01-11 2003-07-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US7241876B2 (en) 1996-01-11 2007-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6861506B1 (en) 1996-01-11 2005-03-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US20020068285A1 (en) * 1996-01-11 2002-06-06 Frudakis Tony N. Compositions and methods for the therapy and diagnosis of breast cancer
US20030125536A1 (en) * 1996-01-11 2003-07-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
CN111983220B (zh) * 2019-05-21 2024-03-19 北京中科纳泰生物科技有限公司 多肽磁性纳米颗粒、其制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1575697A (en) * 1996-01-10 1997-08-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of cancer
EP1876241A3 (en) * 1996-01-11 2008-07-30 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
ZA982968B (en) * 1997-04-09 1998-10-27 Corixa Corp Compositions and methods for the treatment and diagnosis of breast cancer
AU758004B2 (en) * 1997-12-17 2003-03-13 Genset S.A. Extended cDNAs for secreted proteins
CZ2001149A3 (cs) * 1998-07-14 2002-02-13 Corixa Corporation Prostředky a způsoby pro terapii a diagnostiku karcinomu prostaty

Also Published As

Publication number Publication date
CN1352683A (zh) 2002-06-05
AU4213000A (en) 2000-11-14
EP1169444A2 (en) 2002-01-09
HUP0200825A2 (en) 2002-07-29
NO20014805L (no) 2001-12-06
CZ20013575A3 (cs) 2002-10-16
CA2365909A1 (en) 2000-10-19
JP2002541803A (ja) 2002-12-10
NO20014805D0 (no) 2001-10-03
PL350863A1 (en) 2003-02-10
NZ514646A (en) 2005-04-29
KR20020026418A (ko) 2002-04-10
WO2000061753A2 (en) 2000-10-19
MXPA01010186A (es) 2004-08-12
IL145719A0 (en) 2002-07-25
WO2000061753A3 (en) 2001-06-28
AU774824B2 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
BR9808509A (pt) Composições e métodos para o tratamento e diagnóstico do câncer de mama
NZ330887A (en) Monoclonals and polyclonals antibodies for the diagnosis of breast cancer
BR0110091A (pt) Composições e processos para terapia e diagnóstico de câncer de mama
BR0112542A (pt) Composições e métodos papa a terapia e a diagnose de câncer ovariano
PT912898E (pt) Metodo imunologico de deteccao de anticorpos dirigidos contra a transglutaminase (ttg) utilizacao de ttg para o diagnostico e controlo de terapia assim como agente farmaceutico oral contendo ttg
HUP0203035A2 (hu) Prosztatarák terápiájára és diagnózisára alkalmas vegyületek és eljárások
AR031250A1 (es) Composiciones y metodos para la terapia y el diagnostico del cancer de pulmon
HUP9901254A2 (hu) Nemdendrites szerkezetű gerincet alkotó peptid hordozó
WO2000052165A3 (en) Compositions and methods for breast cancer therapy and diagnosis
BR0009573A (pt) Composições e métodos para o tratamento e diagnose do câncer de mama
WO2001071357A3 (en) Diagnosis and treatment of breast cancer
ATE514780T1 (de) Zusammensetzungen für die therapie und diagnose von brustkrebs und verwendung davon
WO2002064741A3 (en) Compositions and methods relating to breast specific genes and proteins
BR0111024A (pt) Composições e métodos para a terapia e diagnóstico de câncer de mama
WO2002077232A3 (en) Compositions and methods relating to breast specific genes and proteins
WO2004053075A3 (en) Compositions, splice variants and methods relating to breast specific genes and proteins
EP1323732A4 (en) BETA-CATENINE NUCLEAR LOCALIZING PROTEIN
ATE282697T1 (de) Vektorkonstrukte zur gentherapeutisch vermittelten radionuklid-therapie entdifferenzierter und medullärer schilddrüsen- karzinome sowie nicht-thyreoidaler tumore und ihrer metastasen
WO2002032954A3 (en) Phosphorylation modifications of apoptin
WO1999037775A3 (en) Compositions and methods for detecting and treating breast cancer
BRPI0413364A (pt) proteases especìficas de ubiquitina
DE60139150D1 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
AR012389A1 (es) Composiciones y metodos para el tratamiento y diagnostico del cancer de seno
WO2002068645A8 (en) Compositions and methods relating to breast specific genes and proteins
ATE501255T1 (de) 84p2a9: prostata- und hodenspezifisches protein, das sehr stark bei prostatakrebs vorkommt

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 22 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.

B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: C12N 15/12; C07K 14/47; C07K 16/18; C07K 19/00; C12N 15/62; A61K 38/17; A61K 39/395; A61K 48/00; C12N 5/08; G01N 33/574; C12Q 1/68.

Ipc: C07K 14/47 (2006.01), A61K 35/12 (2015.01), A61K 3

Ipc: C07K 14/47 (2006.01), A61K 35/12 (2015.01), A61K 3